The case surrounding Wockhardt's' codeine creation practices has ignited a significant controversy. Reports surfaced suggesting possible data falsification and insufficient oversight during the medication's assembly. This led to regulatory investigation from the US Food and Drug Administration, culminating in import limitations and sparking seri… Read More